assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCA_002906395.1_ASM290639v1	CP026273	Klebsiella oxytoca strain KONIH4 plasmid pKOX-ea2b, complete sequence	1	59180-59633	1	CRT	no	csf2gr7,DinG	DinG,csf2gr7	Type IV-A	NNCCGATAACCCCCNCACGCAGGGGAAACACNN	33	1	1	59209-59238	CP026271.1_9164-9193	NA	7	7	TypeIV-A	RT,cas3,cas14j,csa3,DEDDh,DinG,WYL,csf2gr7	NA|66aa|up_8|CP026273.1_54432_54630_-,NA|100aa|up_7|CP026273.1_54768_55068_+,NA|105aa|up_6|CP026273.1_55119_55434_-,NA|144aa|up_5|CP026273.1_55479_55911_-,NA|63aa|up_4|CP026273.1_56064_56253_-,NA|83aa|up_3|CP026273.1_56304_56553_-,NA|109aa|up_2|CP026273.1_56549_56876_-,NA|234aa|down_1|CP026273.1_60742_61444_-,NA|265aa|down_4|CP026273.1_63880_64675_-,NA|96aa|down_5|CP026273.1_64894_65182_-,NA|117aa|down_6|CP026273.1_65402_65753_-,NA|103aa|down_7|CP026273.1_65809_66118_-,NA|139aa|down_8|CP026273.1_66761_67178_+,NA|216aa|down_9|CP026273.1_67278_67926_+	NA|111aa|up_9|CP026273.1_53985_54318_-	pfam06069, PerC, PerC transcriptional activator	NA|66aa|up_8|CP026273.1_54432_54630_-	NA	NA|100aa|up_7|CP026273.1_54768_55068_+	NA	NA|105aa|up_6|CP026273.1_55119_55434_-	NA	NA|144aa|up_5|CP026273.1_55479_55911_-	NA	NA|63aa|up_4|CP026273.1_56064_56253_-	NA	NA|83aa|up_3|CP026273.1_56304_56553_-	NA	NA|109aa|up_2|CP026273.1_56549_56876_-	NA	NA|79aa|up_1|CP026273.1_57355_57592_-	pfam06183, DinI, DinI-like family	NA|290aa|up_0|CP026273.1_57661_58531_-	PRK02951, PRK02951, DNA replication terminus site-binding protein; Provisional	csf2gr7|264aa|down_0|CP026273.1_59700_60492_-	TIGR03115, cas7_csf2, CRISPR type IV/AFERR-associated protein Csf2	NA|234aa|down_1|CP026273.1_60742_61444_-	NA	DinG|625aa|down_2|CP026273.1_61437_63312_-	COG1199, DinG, Rad3-related DNA helicases [Transcription / DNA replication, recombination, and repair]	NA|188aa|down_3|CP026273.1_63311_63875_-	cd09727, Cas6_I-E, CRISPR/Cas system-associated RAMP superfamily protein Cas6e	NA|265aa|down_4|CP026273.1_63880_64675_-	NA	NA|96aa|down_5|CP026273.1_64894_65182_-	NA	NA|117aa|down_6|CP026273.1_65402_65753_-	NA	NA|103aa|down_7|CP026273.1_65809_66118_-	NA	NA|139aa|down_8|CP026273.1_66761_67178_+	NA	NA|216aa|down_9|CP026273.1_67278_67926_+	NA
GCA_002906395.1_ASM290639v1	CP026273	Klebsiella oxytoca strain KONIH4 plasmid pKOX-ea2b, complete sequence	2	99421-99870	2,1	CRT,CRISPRCasFinder	no		DinG,csf2gr7	Orphan	CGANAACCCCCGCACGCAGGGGAAACANNN,CGATAACCCCCGCACGCAGGGGAAACA	30,27	0	0	NA	NA	NA:NA	7,5	7	Orphan	RT,cas3,cas14j,csa3,DEDDh,DinG,WYL,csf2gr7	NA|105aa|up_9|CP026273.1_94381_94696_-,NA|140aa|up_8|CP026273.1_94745_95165_-,NA|101aa|up_7|CP026273.1_95256_95559_-,NA|213aa|up_6|CP026273.1_95570_96209_-,NA|107aa|up_5|CP026273.1_96334_96655_-,NA|186aa|up_2|CP026273.1_97586_98144_-,NA|92aa|up_1|CP026273.1_98213_98489_-,NA|229aa|up_0|CP026273.1_98556_99243_-,NA|86aa|down_0|CP026273.1_99958_100216_-,NA|229aa|down_1|CP026273.1_100607_101294_-,NA|146aa|down_2|CP026273.1_101290_101728_-,NA|221aa|down_3|CP026273.1_101727_102390_-,NA|77aa|down_4|CP026273.1_102392_102623_-,NA|150aa|down_5|CP026273.1_102679_103129_-,NA|61aa|down_6|CP026273.1_103121_103304_-,NA|336aa|down_7|CP026273.1_103335_104343_-	NA|105aa|up_9|CP026273.1_94381_94696_-	NA	NA|140aa|up_8|CP026273.1_94745_95165_-	NA	NA|101aa|up_7|CP026273.1_95256_95559_-	NA	NA|213aa|up_6|CP026273.1_95570_96209_-	NA	NA|107aa|up_5|CP026273.1_96334_96655_-	NA	NA|111aa|up_4|CP026273.1_96928_97261_-	PRK09907, PRK09907, endoribonuclease MazF	NA|82aa|up_3|CP026273.1_97260_97506_-	PRK09798, PRK09798, MazF-MazE toxin-antitoxin system antitoxin MazE	NA|186aa|up_2|CP026273.1_97586_98144_-	NA	NA|92aa|up_1|CP026273.1_98213_98489_-	NA	NA|229aa|up_0|CP026273.1_98556_99243_-	NA	NA|86aa|down_0|CP026273.1_99958_100216_-	NA	NA|229aa|down_1|CP026273.1_100607_101294_-	NA	NA|146aa|down_2|CP026273.1_101290_101728_-	NA	NA|221aa|down_3|CP026273.1_101727_102390_-	NA	NA|77aa|down_4|CP026273.1_102392_102623_-	NA	NA|150aa|down_5|CP026273.1_102679_103129_-	NA	NA|61aa|down_6|CP026273.1_103121_103304_-	NA	NA|336aa|down_7|CP026273.1_103335_104343_-	NA	NA|253aa|down_8|CP026273.1_104513_105272_-	cd02440, AdoMet_MTases, S-adenosylmethionine-dependent methyltransferases (SAM or AdoMet-MTase), class I;  AdoMet-MTases are enzymes that use S-adenosyl-L-methionine (SAM or AdoMet) as a substrate for methyltransfer, creating the product S-adenosyl-L-homocysteine (AdoHcy)	NA|53aa|down_9|CP026273.1_105644_105803_+	PRK09738, PRK09738, small toxic polypeptide; Provisional
